0 Commentaires
0 Parts
359 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
HER2 Positive Breast Cancer Treatment market Research Report: Industry Trends, Demand and Outlook"HER2 Positive Breast Cancer Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the...0 Commentaires 0 Parts 304 Vue 0 Aperçu
-
HER2 Positive Breast Cancer Treatment Market Research: Industry Evolution and Forecast Outlook"Global Demand Outlook for Executive Summary HER2 Positive Breast Cancer Treatment Market Size and Share Data Bridge Market Research analyses a growth rate in the global HER2 positive breast cancer treatment market in the forecast period 2022-2029. The expected CAGR of global HER2 positive breast cancer treatment market is tend to be around 1.50% in the mentioned forecast...0 Commentaires 0 Parts 648 Vue 0 Aperçu
-
Oral Cancer Treatment Market Graph: Growth, Share, Value, Size, and Insights"Executive Summary Oral Cancer Treatment Market Size and Share Forecast Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. With a capable and wide-ranging market research study, Oral Cancer Treatment...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Oral Cancer Treatment Market Opportunities: Growth, Share, Value, Size, and Scope"Global Demand Outlook for Executive Summary Oral Cancer Treatment Market Size and Share Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. In order to make smart decisions about budgeting, Market...0 Commentaires 0 Parts 907 Vue 0 Aperçu
-
Oral Cancer Treatment Market Opportunities: Growth, Share, Value, Size, and Scope"Executive Summary Oral Cancer Treatment Market Size and Share Forecast Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. With a capable and wide-ranging market research study, Oral Cancer Treatment...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Oral Cancer Treatment Market Research Report: Growth, Share, Value, Size, and Analysis"Executive Summary: Oral Cancer Treatment Market Size and Share by Application & Industry Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. The leading Oral Cancer Treatment Market analysis report...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Anti-Metabolite Drugs Market: Cancer Treatment Innovations Driving Growth"In-Depth Study on Executive Summary Anti-Metabolite Drugs Market Size and Share Anti-metabolite drugs market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.60% in the above mentioned forecast period. The Anti-Metabolite Drugs Market report contains market insights and analysis...0 Commentaires 0 Parts 538 Vue 0 Aperçu
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Commentaires 0 Parts 227 Vue 0 Aperçu
-
Cancer Treatment Facilities Market Size, Analysis, Demand, Key Companies, and Forecast To 2032Emergen Research’s latest market research report focuses on the global Cancer Treatment Facilities market, and the report provides in-depth analysis of each of its major segments. Reports about the global Cancer Treatment Facilities market provide a comprehensive overview of the market, including market size, revenue growth rate, industry statistics, revenue shares among regional markets,...0 Commentaires 0 Parts 381 Vue 0 Aperçu
-
Cell Cycle Inhibitors Market Emerging Cancer Therapies Reshaping Treatment ApproachesAccording to the latest report published by Data Bridge Market Research, the Cell Cycle Inhibitors Market CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. Global Cell Cycle Inhibitors Market report analyses the key...0 Commentaires 0 Parts 124 Vue 0 Aperçu
-
Cervical Cancer Treatment Market Innovations Driving Better Patient OutcomesAccording to the latest report published by Data Bridge Market Research, the Cervical Cancer Treatment Market CAGR Value Data Bridge Market Research analyses a growth rate in the cervical cancer treatment market in the forecast period 2023-2030. The expected CAGR of mesothelioma treatment market is tend to be around 5.5% in the mentioned forecast period. The market was valued at...0 Commentaires 0 Parts 119 Vue 0 Aperçu
-
Asia-Pacific Stroke Diagnostics Market Leaders: Growth, Share, Value, Analysis, and Trends"Executive Summary Asia-Pacific Stroke Diagnostics Market: Growth Trends and Share Breakdown Asia-Pacific stroke diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.2% in the forecast period of 2021 to 2028 and is expected to reach USD 6,969.06 million by 2028. The...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Breakthrough Therapies and Innovation Trends Reshaping the Cancer Pain Management Solutions Market by 2031The Cancer Pain Management Solutions Market is undergoing rapid transformation as advancements in therapeutics, digital health technologies, and patient-centric care models redefine oncology support systems.The integration of pharmacological treatments, medical devices, and non-invasive therapies continues to expand the scope of pain management strategies across global healthcare systems....0 Commentaires 0 Parts 844 Vue 0 Aperçu
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek